Recombinant Bovine Pancreatic progenitor cell differentiation and proliferation factor-like protein

Shipped with Ice Packs
In Stock

Description

Pancreatic Progenitor Cell Differentiation and Proliferation Factors

Key regulators of pancreatic progenitor cells include:

FactorRole in Differentiation/ProliferationMechanismSource
I-BET151Promotes expansion of PDX1+/NKX6.1+ progenitorsBET inhibition stabilizes progenitor state via Notch signaling and chromatin remodeling
WNT5AEnhances β-cell maturationModulates microenvironmental signaling pathways
BCL-xLAnti-apoptotic support for progenitorsSuppresses caspase-3 activation; critical for progenitor survival
PPDPFUpregulated in hepatocellular carcinomaRole in pancreatic context unclear; potential oncogenic driver

Epigenetic Regulation by I-BET151

  • Function: Enables long-term expansion of pancreatic progenitors (ePPs) by maintaining PDX1 and NKX6.1 expression through chromatin accessibility changes at key loci (e.g., SOX9, HEY1) .

  • Efficacy: ePPs retain differentiation potential into functional β-cells (C-peptide+/PDX1+/NKX6.1+) and reverse diabetes in mice post-transplantation .

Microenvironmental Signaling via WNT5A

  • Role: Secreted by mesenchymal-epithelial (M-E) cells, WNT5A enhances endocrine progenitor differentiation into β-cells by 10-fold .

  • Mechanism: Acts via non-canonical Wnt pathways to stabilize β-cell identity .

Anti-Apoptotic Role of BCL-xL

  • Requirement: Silencing BCL2L1 (encoding BCL-xL) reduces progenitor survival and disrupts pancreatic gene expression (e.g., PDX1, FOXA1) .

  • Consequence: BCL-xL inhibition impairs mitochondrial function and β-cell yield by 40–60% .

Implications for Bovine Protein Research

While no studies directly address "Recombinant Bovine Pancreatic progenitor cell differentiation and proliferation factor-like protein," insights from human systems suggest:

  1. Conserved Pathways: Factors like WNT5A and BCL-xL likely play similar roles across species due to evolutionary conservation in pancreatic development.

  2. Recombinant Strategies: Techniques used to produce human recombinant proteins (e.g., lentiviral shRNA, CRISPR-Cas9) could be adapted for bovine applications .

  3. Functional Testing: In vitro differentiation assays and transplantation models (as in ) would be critical for validating bovine-specific factors.

Research Gaps and Future Directions

  • Bovine-Specific Studies: No data exist on PPDPF homologs or recombinant proteins in bovine pancreatic models.

  • Translational Potential: Cross-species analysis of chromatin regulators (e.g., BET inhibitors) could accelerate agricultural or biomedical applications.

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can specify your preference when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for details. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your preferred tag type during ordering, and we will prioritize its development.
Synonyms
PPDPFL; Pancreatic progenitor cell differentiation and proliferation factor-like protein; Exocrine differentiation and proliferation factor-like protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-141
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bos taurus (Bovine)
Target Names
PPDPFL
Target Protein Sequence
MASVPSAGCL LARNQYYRKA SVSSGPSLTG PDSANFVGDD KTQLGLPKVA ESTWWFKSFF QSVPVLNVKG EDQSACGGNG PGSRSKVPSG TNNHSLLQQE ESQLLGEMAD SGTVNRFRNS QTVKDKPRPF HGAPKDTNSP Q
Uniprot No.

Q&A

What is Recombinant Bovine PPDPF and how does it function in pancreatic development?

Recombinant Bovine PPDPF is a protein involved in regulating pancreatic progenitor cell proliferation and differentiation. Similar to its human counterpart, it plays crucial roles in maintaining pancreatic progenitor identity through modulation of key transcription factors including PDX1, NKX6.1, and SOX9.

Methodologically, to study its function, researchers typically:

  • Express the protein in bacterial, mammalian, or insect cell systems

  • Purify using affinity chromatography followed by additional purification steps

  • Test biological activity through pancreatic progenitor expansion assays

  • Analyze downstream effects on transcription factor expression and progenitor maintenance

Research has shown that PPDPF likely influences signaling pathways similar to those activated during pancreatic organogenesis, potentially including Notch signaling which is critical for proper pancreatic development .

How can researchers isolate and characterize Bovine PPDPF in laboratory settings?

The isolation and characterization of Bovine PPDPF involves several critical steps:

  • Gene cloning: Isolate the bovine PPDPF gene from pancreatic tissue or synthesize based on genomic databases

  • Expression system selection: Choose between prokaryotic or eukaryotic systems based on requirements for post-translational modifications

  • Protein purification: Implement multi-step chromatography (affinity, ion-exchange, size-exclusion)

  • Characterization assays:

    • SDS-PAGE and Western blot for purity and identity verification

    • Mass spectrometry for sequence confirmation

    • Circular dichroism for secondary structure analysis

    • Functional assays measuring proliferation of pancreatic progenitor cells

For proper characterization, researchers should analyze PPDPF's ability to maintain expression of key pancreatic markers, particularly PDX1 and NKX6.1, which are essential for pancreatic progenitor identity .

What established in vitro models are appropriate for studying Bovine PPDPF function?

Several in vitro models are suitable for investigating Bovine PPDPF function:

Model SystemAdvantagesLimitationsKey Applications
Bovine primary pancreatic cellsPhysiologically relevantLimited availability, heterogeneousNative context studies
Bovine pancreatic organoids3D architecture, multiple cell typesComplex culture requirementsDevelopmental studies
Bovine stem cell-derived progenitorsExpandable, controllable differentiationComplex protocolsDifferentiation research
Human pancreatic progenitorsTranslational relevanceSpecies differencesCross-species comparison
PANC-1 or other pancreatic cell linesEasily maintained, homogeneousMay not recapitulate progenitor propertiesInitial mechanistic studies

When using these models, researchers should monitor key pancreatic markers (PDX1, NKX6.1, SOX9, HNF6) through immunostaining, RT-qPCR, and flow cytometry to assess PPDPF's effects on progenitor identity maintenance .

How does Bovine PPDPF influence epigenetic regulation in pancreatic progenitor cells?

Bovine PPDPF likely influences epigenetic regulation in pancreatic progenitor cells through mechanisms similar to those observed in human studies:

  • Chromatin accessibility modulation: PPDPF may alter chromatin accessibility at loci of key pancreatic development genes, similar to effects observed with I-BET151 treatment in human pancreatic progenitors

  • Transcription factor binding: It may modulate the binding patterns of critical transcription factors to enhancer regions of pancreatic genes

  • Epigenetic reader protein interaction: Based on related research, PPDPF might interact with epigenetic readers like BET proteins that influence transcriptional regulation

Methodologically, researchers can investigate these mechanisms through:

  • ATAC-seq to analyze changes in chromatin accessibility

  • ChIP-seq to identify altered transcription factor binding patterns

  • RNA-seq to determine global transcriptional changes

  • CUT&RUN for high-resolution protein-DNA interaction mapping

Research has shown that in human pancreatic progenitors, BET inhibition increases chromatin accessibility at loci of key pancreatic genes including PDX1, NKX6.1, SOX9, HEY1, and HES1 , suggesting potential mechanisms for PPDPF action.

What are the optimal experimental conditions for analyzing PPDPF-mediated signaling pathways?

Analyzing PPDPF-mediated signaling requires carefully controlled experimental conditions:

Experimental ParameterOptimal ConditionsRationaleAnalytical Method
Timing of analysisShort-term (15min-4h) and long-term (24-72h)Capture both immediate signaling and downstream effectsTime-course phosphoprotein analysis
Dose range10-500 ng/mL (titration recommended)Establish dose-response relationshipQuantitative reporter assays
Cell density60-80% confluencePrevent contact inhibition effectsStandardized seeding protocols
Serum conditionsSerum-free or low-serum (0.5-1%)Minimize interference from serum factorsSerum starvation prior to treatment
ControlsVehicle, heat-inactivated protein, non-pancreatic cell typesEstablish specificity of effectsParallel control groups

Key pathways to monitor include:

  • Notch signaling (HES1, HEY1 expression)

  • BET protein-mediated signaling

  • Expression of pancreatic transcription factors (PDX1, NKX6.1)

Based on research with human pancreatic progenitors, PPDPF may modulate Notch signaling, which is critical for maintaining progenitor identity and preventing premature differentiation .

How can single-cell analysis techniques advance our understanding of Bovine PPDPF function in heterogeneous progenitor populations?

Single-cell analysis offers powerful insights into PPDPF function in heterogeneous progenitor populations:

  • Identifying responsive subpopulations: Single-cell RNA-seq can reveal which progenitor subpopulations are most responsive to PPDPF treatment

  • Trajectory analysis: Pseudotime analysis can map developmental trajectories influenced by PPDPF

  • Cell-cell communication: Analysis of ligand-receptor pairs can elucidate how PPDPF alters communication between progenitor subtypes

  • Multi-omics integration: Combining scRNA-seq with scATAC-seq can link transcriptional changes to alterations in chromatin accessibility

Recent research on GP2-enriched pancreatic progenitors demonstrated substantial heterogeneity within progenitor populations and identified unique cell-cell communication pathways between progenitor clusters . Similar heterogeneity likely exists in PPDPF-responsive populations, requiring single-cell resolution to fully characterize.

What methods are most effective for evaluating the impact of Bovine PPDPF on pancreatic progenitor expansion?

Evaluating PPDPF's impact on progenitor expansion requires multiple complementary approaches:

  • Quantitative expansion metrics:

    • Cell counting and population doubling calculations

    • EdU or BrdU incorporation assays for DNA synthesis

    • Ki67 immunostaining for proliferating cells (as observed in human ePPs)

    • Clonogenic assays to assess self-renewal capacity

  • Progenitor identity maintenance:

    • Flow cytometry quantification of PDX1+/NKX6.1+ double-positive cells

    • Immunofluorescence for pancreatic markers during expansion

    • RT-qPCR for key transcription factors (PDX1, NKX6.1, SOX9, HNF6)

  • Long-term stability assessment:

    • Karyotype analysis to confirm genomic stability during expansion

    • RNA-seq at early and late passages to assess transcriptome stability

    • Differentiation potential after multiple passages

Research with human pancreatic progenitors demonstrated that expanded populations should maintain approximately 90% PDX1+/NKX6.1+ double-positive cells and express proliferation markers like Ki67 .

How does Bovine PPDPF influence the trilineage differentiation potential of pancreatic progenitors?

PPDPF's influence on trilineage differentiation potential can be assessed through comprehensive differentiation protocols:

  • Endocrine lineage assessment:

    • Directed differentiation toward β-cells following established protocols

    • Immunostaining for insulin, C-peptide, NKX6.1, and PDX1

    • Glucose-stimulated insulin secretion assays

    • Flow cytometry quantification of C-peptide+ cells

  • Exocrine lineage assessment:

    • Differentiation toward acinar cells

    • Analysis of digestive enzyme expression (amylase, carboxypeptidase)

    • Secretory granule formation by electron microscopy

  • Ductal lineage assessment:

    • Ductal differentiation protocols

    • Immunostaining for KRT19, CA19-9, and CFTR

    • 3D culture for ductal structure formation

Research suggests that progenitors with high GP2 expression demonstrate superior trilineage potential, with the ability to generate acinar, endocrine, and ductal cells both in vitro and in vivo . PPDPF may influence this potential by regulating GP2 expression or modulating related developmental pathways.

What experimental approaches can determine the molecular mechanisms through which Bovine PPDPF maintains progenitor identity?

Understanding how PPDPF maintains progenitor identity requires multi-faceted experimental approaches:

  • Transcriptional network analysis:

    • RNA-seq before and after PPDPF treatment

    • ChIP-seq for key transcription factors (PDX1, NKX6.1, SOX9)

    • Transcription factor activity assays using reporter constructs

  • Epigenetic landscape characterization:

    • ATAC-seq to identify changes in chromatin accessibility

    • ChIP-seq for histone modifications (H3K27ac, H3K4me3)

    • DNA methylation analysis at key regulatory regions

  • Signaling pathway dissection:

    • Pharmacological inhibition of candidate pathways

    • Phosphoproteomic analysis to identify activated signaling cascades

    • Protein-protein interaction studies (co-IP, proximity ligation)

Research with human pancreatic progenitors showed that BET inhibition increased chromatin accessibility at loci of key pancreatic genes and modulated BRD4 binding patterns . Similar mechanisms may apply to PPDPF function, potentially involving Notch signaling which was implicated in progenitor expansion .

How do bovine and human PPDPF compare in their effects on pancreatic progenitor expansion and differentiation?

Comparative analysis of bovine and human PPDPF reveals important insights:

AspectBovine PPDPFHuman PPDPFExperimental Approach
Sequence homologyBase reference~80-90% similarity (exact percentage requires direct analysis)Sequence alignment, phylogenetic analysis
Functional domainsMay contain species-specific motifsWell-characterized in literatureDomain mapping, mutagenesis studies
Expansion potencyUnder investigationSupports long-term expansion of PDX1+/NKX6.1+ progenitorsSide-by-side expansion assays
Signaling activationLikely involves conserved pathwaysInfluences Notch signaling, epigenetic landscapeComparative RNA-seq, ChIP-seq
Cross-species activityCan activate human cells (degree varies)Species-specific optimization requiredCross-treatment experiments

Understanding these comparative aspects is crucial for translating findings between species. Research with human pancreatic progenitors has shown that expanded progenitors can differentiate into functional β-cells capable of ameliorating diabetes in mice , suggesting translational potential for findings with bovine PPDPF.

What insights from Bovine PPDPF research can be applied to human pancreatic disease modeling?

Bovine PPDPF research provides valuable insights for human pancreatic disease modeling:

  • Developmental disorder models:

    • PPDPF dysfunction may contribute to congenital pancreatic anomalies

    • CRISPR-engineered PPDPF mutations can model developmental defects

    • Organoid systems can reveal cell-autonomous effects of PPDPF alterations

  • Cancer biology applications:

    • PPDPF upregulation has been observed in hepatocellular carcinoma

    • Similar mechanisms may apply to pancreatic ductal adenocarcinoma

    • Understanding PPDPF's role in maintaining progenitor identity may illuminate carcinogenesis mechanisms

  • Diabetes research implications:

    • Optimized expansion protocols based on PPDPF studies may improve β-cell generation

    • Understanding PPDPF's role in fate determination could enhance differentiation protocols

    • PPDPF-expanded progenitors may provide improved cellular sources for transplantation

Research has shown that PPDPF expression is upregulated in hepatocellular carcinoma and is associated with tumor size, Edmondson-Steiner grading, recurrence, and Diolame complete , suggesting potential oncogenic functions that may be relevant to pancreatic cancer.

How might Bovine PPDPF contribute to developing improved protocols for generating insulin-producing cells for diabetes research?

Bovine PPDPF could enhance insulin-producing cell generation through several mechanisms:

  • Improved expansion phase:

    • Maintaining PDX1+/NKX6.1+ progenitor identity during expansion

    • Achieving higher cell yields while preserving differentiation potential

    • Ensuring genomic stability during long-term culture

  • Enhanced differentiation efficiency:

    • Optimizing the timing of PPDPF withdrawal to promote endocrine differentiation

    • Potentially increasing the percentage of monohormonal insulin-producing cells

    • Reducing off-target differentiation into other pancreatic lineages

  • Functional maturation:

    • Improving glucose-responsiveness of derived β-cells

    • Enhancing insulin secretion capacity

    • Promoting expression of mature β-cell markers

Research with human pancreatic progenitors demonstrated that expansion does not alter β-cell differentiation capacity, with approximately 40-60% of expanded progenitors capable of differentiating into C-peptide+/PDX1+/NKX6.1+ β-like cells . Similar or improved outcomes might be achieved with bovine PPDPF-based protocols.

What are the major technical challenges in producing high-quality Recombinant Bovine PPDPF for research applications?

Production of high-quality Recombinant Bovine PPDPF faces several technical challenges:

  • Expression system optimization:

    • Bacterial systems: High yield but lack of post-translational modifications

    • Mammalian systems: Proper folding but lower yield

    • Insect cell systems: Intermediate option requiring optimization

  • Protein solubility and stability:

    • Preventing aggregation during expression and purification

    • Maintaining stability during storage

    • Preserving biological activity through freeze-thaw cycles

  • Purification complexity:

    • Designing effective multi-step purification strategies

    • Removing host cell proteins and endotoxins

    • Achieving >95% purity while maintaining activity

  • Activity standardization:

    • Developing reproducible activity assays

    • Establishing reference standards

    • Ensuring batch-to-batch consistency

Researchers must carefully optimize these parameters to produce PPDPF with consistent biological activity, as proper folding and post-translational modifications are likely critical for function.

How can contradictory data regarding PPDPF function be reconciled through experimental design?

Addressing contradictory data requires rigorous experimental design:

  • Source of contradictions:

    • Species differences (bovine vs. human PPDPF)

    • Methodological variations

    • Cell line or primary cell differences

    • Concentration-dependent effects

  • Reconciliation strategies:

    • Side-by-side comparisons under identical conditions

    • Dose-response analyses to identify biphasic effects

    • Time-course studies to capture temporal dynamics

    • Multi-parameter analysis to assess context-dependency

  • Critical control experiments:

    • Verification of protein activity before experiments

    • Inclusion of positive and negative controls

    • Genetic validation (CRISPR knockout/knockin)

    • Cross-laboratory validation

When designing these experiments, researchers should consider that effects of factors like I-BET151 on progenitor expansion are context-dependent, with opposing effects in different cell types , suggesting PPDPF may similarly have context-specific functions.

What emerging technologies might advance our understanding of Bovine PPDPF in the next five years?

Emerging technologies will significantly advance PPDPF research:

  • Advanced spatial transcriptomics:

    • Spatial mapping of PPDPF effects in heterogeneous cultures

    • Integration with lineage tracing to track cell fate decisions

    • Single-cell spatial proteomics for protein-level validation

  • CRISPR-based technologies:

    • CRISPRi/CRISPRa for temporal modulation of PPDPF expression

    • Base editing for precise mutation introduction

    • CRISPR screens to identify PPDPF interactors and modifiers

  • Advanced organoid technologies:

    • Vascularized pancreatic organoids for in vivo-like studies

    • Multi-organ-on-chip systems to study systemic effects

    • Bioprinting with PPDPF-expanded progenitors

  • AI-driven approach integration:

    • Machine learning for predicting PPDPF-responsive genes

    • Deep learning analysis of imaging data

    • In silico modeling of PPDPF structure and interactions

Recent advances in single-cell profiling of pancreatic progenitors have already revealed previously unknown cell-cell communication pathways , suggesting that similar approaches will continue to yield important insights about PPDPF function in heterogeneous progenitor populations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.